Biosimilars: How Can Payers Get Long-Term Savings?

PharmacoEconomics
Jorge Mestre-FerrandizMikel Berdud

Abstract

The term 'biosimilar' refers to an alternative similar version of an off-patent innovative originator biotechnology product (the 'reference product'). Several biosimilars have been approved in Europe, and a number of top-selling biological medicines have lost, or will lose, patent protection over the next 5 years. We look at the experience in Europe so far. The USA has finally implemented a regulatory route for biosimilar approval. We recommend that European and US governments and payers take a strategic approach to get value for money from the use of biosimilars by (1) supporting and incentivising generation of high-quality comprehensive outcomes data on the effectiveness and safety of biosimilars and originator products; and (2) ensuring that incentives are in place for budget holders to benefit from price competition. This may create greater willingness on the part of budget holders and clinicians to use biosimilar and originator products with comparable outcomes interchangeably, and may drive down prices. Other options, such as direct price cuts for originator products or substitution rules without outcomes data, are likely to discourage biosimilar entry. With such approaches, governments may achieve a one-off cut in origin...Continue Reading

References

Mar 16, 2007·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M A DewUNKNOWN American Society of Transplantation
Aug 5, 2011·The New England Journal of Medicine·Steven KozlowskiRachel Behrman Sherman
Jan 22, 2014·Nature Reviews. Drug Discovery·Henry GrabowskiMaria Salgado
Mar 8, 2014·Health Policy·Sandro CurtoLivio Garattini
Sep 6, 2014·Applied Health Economics and Health Policy·François BocquetClaude Le Pen
Sep 10, 2014·Journal of Health Economics·Joan Costa-FontNebibe Varol
Feb 6, 2015·Applied Health Economics and Health Policy·Katelijne van de VoorenLivio Garattini

❮ Previous
Next ❯

Citations

Jan 8, 2017·Applied Health Economics and Health Policy·Sabine VoglerZaheer-Ud-Din Babar
Feb 8, 2018·Applied Health Economics and Health Policy·Don HusereauCarl Selya-Hammer
Feb 15, 2019·Expert Review of Pharmacoeconomics & Outcomes Research·Lajos HornyákImre Boncz
May 7, 2019·Expert Opinion on Biological Therapy·Christopher J EdwardsAurelian Amiot
Apr 16, 2020·British Journal of Clinical Pharmacology·Robert Likic
Jul 26, 2017·Journal of Market Access & Health Policy·Cécile RémuzatMondher Toumi
Jul 1, 2017·PharmacoEconomics·Steven SimoensLesley G Shane
Jan 25, 2018·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Sascha GerdesMarc A Radtke
Jan 15, 2020·Pharmaceutical Medicine·Stanton R Mehr, Richard A Brook
Feb 7, 2017·Current Treatment Options in Gastroenterology·Shannon Chang, Stephen Hanauer
Aug 9, 2018·Applied Health Economics and Health Policy·Jaime EspinClaudio Jommi
May 13, 2020·BMC Health Services Research·Love LinnérBjörn Wettermark
Dec 1, 2018·Future Oncology·Hope S RugoGeraint Morgan
Jun 13, 2020·International Journal of Environmental Research and Public Health·Katharina E Blankart, Friederike Arndt
Feb 9, 2018·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Sascha GerdesMarc A Radtke
Mar 28, 2019·Clinical Rheumatology·S C KowalskiJ Kay
Dec 12, 2018·Bioprocess and Biosystems Engineering·Steffen GroßhansJürgen Hubbuch
Nov 21, 2020·Pharmaceuticals·Arnold G VultoSebastian Gonzalez-McQuire
Apr 4, 2021·Pharmaceuticals·Félix Lobo, Isabel Río-Álvarez

❮ Previous
Next ❯

Software Mentioned

Remsima
SWITCH

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Related Papers

Journal of Renal Care
Paul Wilson, Cheryl Wood
International Journal of Applied & Basic Medical Research
Rajiv Kumar, Jagjit Singh
Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria
Alba Martos-RosaPedro José Acosta-Robles
Journal of Diabetes Science and Technology
L Heinemann
© 2022 Meta ULC. All rights reserved